amphetamine has been researched along with arginine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Smith, RP | 1 |
| Connor, JD; Pardridge, WM | 1 |
| Pataky, I; Szilágyi, KA | 1 |
| Bowyer, JF | 1 |
| Amir, S; Deschamps, SE; Stewart, J | 1 |
| Del Arco, A; Martínez, R; Mora, F | 1 |
| Celik, T; Kayír, H; Uzbay, IT; Zaglí, U | 1 |
| Harro, J; Kask, A | 1 |
| Battisti, JJ; Shreffler, CB; Uretsky, NJ; Wallace, LJ | 1 |
| Chen, PN; Hsieh, YS; Kuo, DY; Liao, JM; Yu, CH | 1 |
| Balenovic, I; Blagaic, AB; Cilic, M; Drmic, D; Filipcic, I; Ilic, S; Kokot, A; Seiwerth, S; Sikiric, P; Strbe, S; Tvrdeic, A; Vukojevic, J; Zemba Cilic, A; Zemba, M; Zoricic, Z | 1 |
1 review(s) available for amphetamine and arginine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for amphetamine and arginine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cyanate and thiocyanate: acute toxicity.
Topics: Amphetamine; Animals; Antidotes; Arginine; Cyanates; Female; Methemoglobin; Mice; Morphine; Oxyhemoglobins; Phenobarbital; Seizures; Thiocyanates; Thiosulfates; Tremor | 1973 |
Saturable transport of amphetamine across the blood-brain barrier.
Topics: Amphetamine; Animals; Arginine; Binding, Competitive; Biological Transport; Blood-Brain Barrier; Carbon Isotopes; Dextroamphetamine; Diffusion; Dopamine; Male; Methylphenidate; Phenethylamines; Phenylalanine; Phenylephrine; Rats; Tritium | 1973 |
[Serum arginine level in experimental spasm and excitation].
Topics: Amphetamine; Animals; Arginine; Azoles; Electroshock; Motor Activity; Rats; Seizures | 1967 |
The role of hyperthermia in amphetamine's interactions with NMDA receptors, nitric oxide, and age to produce neurotoxicity.
Topics: Aging; Amphetamine; Animals; Arginine; Brain; Dizocilpine Maleate; Fever; Glutamic Acid; Haloperidol; Methamphetamine; Neurotoxins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Receptors, N-Methyl-D-Aspartate; Stereoisomerism | 1995 |
Inhibition of nitric oxide synthase does not block the development of sensitization to the behavioral activating effects of amphetamine.
Topics: Amino Acid Oxidoreductases; Amphetamine; Analysis of Variance; Animals; Arginine; Binding, Competitive; Dopamine; Male; Microdialysis; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Second Messenger Systems | 1994 |
Amphetamine increases extracellular concentrations of glutamate in the prefrontal cortex of the awake rat: a microdialysis study.
Topics: Amphetamine; Animals; Arginine; Calcium; Dose-Response Relationship, Drug; Extracellular Space; Glutamic Acid; Glutamine; Infusions, Parenteral; Male; Microdialysis; Prefrontal Cortex; Rats; Rats, Wistar; Taurine | 1998 |
Nitric oxide synthase inhibition blocks amphetamine-induced locomotor activity in mice.
Topics: Amphetamine; Animals; Arginine; Dopamine Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Male; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase | 1999 |
Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304.
Topics: Aggression; Amphetamine; Animals; Apomorphine; Arginine; Behavior, Animal; Central Nervous System Stimulants; Dopamine Agonists; Injections, Intraventricular; Injections, Subcutaneous; Male; Microinjections; Motor Activity; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 2000 |
NMDA antagonists block expression of sensitization of amphetamine- and apomorphine-induced stereotypy.
Topics: Amphetamine; Animals; Apomorphine; Arginine; Behavior, Animal; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Indazoles; Male; Mice; Nitric Oxide Synthase; Piperazines; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior | 2000 |
The neuropeptide Y Y1 receptor knockdown modulates activator protein 1-involved feeding behavior in amphetamine-treated rats.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Appetite; Arginine; Chromatin Immunoprecipitation; Feeding Behavior; Gene Knockdown Techniques; Hypothalamus; Injections, Intraventricular; Male; Neuropeptide Y; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Receptors, Neuropeptide Y; Transcription Factor AP-1 | 2013 |
Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophrenia.
Topics: Amphetamine; Animals; Apomorphine; Arginine; Behavior, Animal; Catalepsy; Disease Models, Animal; Dizocilpine Maleate; Dopamine Agents; Enzyme Inhibitors; Haloperidol; Male; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Proteins; Rats; Rats, Wistar; Schizophrenia | 2021 |